Cuts to CDC’s HIV Program Will Spell Disaster, HIV Advocate Says
The Centers for Disease Control and Prevention (CDC) Division of HIV Prevention tracks outbreaks, provides education and establishes guidelines for the United States and the world, according to Terri L. Wilder, MSW, HIV/Aging Policy Advocate at SAGE, an organization that serves LGBTQ+ elders.
The Centers for Disease Control and Prevention (CDC) Division of HIV Prevention may be in trouble, according to today’s announcement from the U.S. Department of Health and Human Services stating the Trump administration will cut approximately 10,000 jobs under the HHS. The change comes as part of President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.”
Terri L. Wilder, MSW, an HIV/aging policy advocate at the elder LGBTQ+ organization SAGE, spoke with Managed Healthcare Executive and shared why the CDC’s Division of HIV Prevention is an important resource.
“The CDC is really important to public health in the United States and quite frankly, the world, because the world looks to the CDC for guidance,” Wilder said. “The CDC creates the HIV screening guidelines available to healthcare providers to guide them in how to offer HIV testing to the patients that come into their practice. [The CDC] exports these policies. It's not just people in the United States that are healthcare providers that go to the CDC website. It's healthcare and public health providers around the world, because the CDC is a trusted source of information.”
Approximately 1.2 million people are living with HIV in the United States, and an estimated 13% don’t know they have it, according to the CDC. Cases have fallen 12% from 2018 to 2022, in which 31,800 new cases were reported.
Funding and restructuring rumors began to swirl last week, thanks to an article published by the Wall Street Journal. The article reported that the HHS had been debating whether to drastically cut funding.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
March 27th 2025Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi syndrome. The price is based on a patient’s weight, and the average patient in the clinical trials would have had an average annual cost of $466,200 for the first year.
Read More
Medicare Costs Rise in 2025 With Higher Part D Premiums, Advantage Deductibles
March 27th 2025During last year’s enrollment period, millions of Medicare beneficiaries reviewed their coverage options and selected new Medicare plans for the 2025 calendar year due to changes including the plans being offered, increases in premiums and more, according to an eHealth analysis.
Read More
